Crystal structure of bumetanide, C 17 H 20 N 2 O 5 S
Source abstract
Abstract
The crystal structure of bumetanide has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Bumetanide crystallizes in space group P -1 (#2) with a = 5.00168(4), b = 9.22649(3), c = 19.59924(14) Å, α = 80.7941(5), β = 82.8401(7), γ = 86.8148(7)°, V = 885.268(9) Å 3 , and Z = 2. The crystal structure is layered with the double layers parallel to the ab plane. The exterior of the layer is composed of hydrocarbon portions of the molecule, both phenyl rings and butyl side chains. The central portion of the bilayer contains the hydrogen-bonding regions, both the carboxylic acid dimers and the hydrogen bonds involving the sulfonamide groups. The molecular conformations of bumetanide in this current triclinic structure and the previously-determined monoclinic polymorph FEDGON are very similar, as are the energies of the two polymorphs. The powder pattern is included in the Powder Diffraction File™ as entry 00-066-1609.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Thermal and Kinetic Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
2. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
3. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
4. Wavefunction, Inc. (2017). Spartan ‘16 Version 2.0.1, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine CA 92612.
5. Turner M. J. , McKinnon J. J. , Wolff S. K. , Grimwood D. J. , Spackman P. R. , Jayatilaka D. , and Spackman M. A. (2017). CrystalExplorer17 (University of Western Australia). http://hirshfeldsurface.net.
6. 10.1107/S002188980100224210.1107/S0021889801002242 ↗
7. 10.1063/1.296926010.1063/1.2969260 ↗
8. A new law of crystal morphology extending the law of Bravais
9. Etudes sur la loi de Bravais
10. 10.1021/ci049780b10.1021/ci049780b ↗
11. Bravais · 1866
12. 2017
13. 10.1107/S002188981301311310.1107/S0021889813013113 ↗
14. 10.1017/S088571561700028810.1017/S0885715617000288 ↗
15. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
16. 10.1021/ar00172a00510.1021/ar00172a005 ↗
17. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
18. 10.1007/BF0054909610.1007/BF00549096 ↗
19. 10.1107/S010876819901508610.1107/S0108768199015086 ↗
20. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
21. 2013
22. 10.1002/qua.2465810.1002/qua.24658 ↗
23. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
24. 10.1107/S002188989400421810.1107/S0021889894004218 ↗
25. 10.1063/1.46788210.1063/1.467882 ↗
26. 10.1002/anie.19951555110.1002/anie.199515551 ↗
27. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
28. Larson A. C. , and Von Dreele R. B. (2004). General Structure Analysis System, (GSAS), (Los Alamos National Laboratory Report LAUR 86-784).
29. 10.1016/j.neuropharm.2012.05.04510.1016/j.neuropharm.2012.05.045 ↗
30. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
31. Open Babel: an open chemical toolbox
32. 10.1002/jcc.2315310.1002/jcc.23153 ↗
33. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
34. 2017
35. 10.1016/S0099-5428(08)60240-310.1016/S0099-5428(08)60240-3 ↗
36. Bernstein J. , and Zevin L. (1990). “Bumetanide,” ICDD Grant-in-Aid.
37. 10.1021/acs.cgd.7b0053110.1021/acs.cgd.7b00531 ↗